Susan P. Perrine

Corporate Officer/Principal at

Boston University

Consumer Services

Health Technology

Profile

Susan P.
Perrine is the founder of HemaQuest Pharmaceuticals, Inc. which was founded in 2007.
She held the title of CSO & VP-Clinical Affairs in 2010.
Dr. Perrine is also the founder of Viracta Subsidiary, Inc. Currently, she is a Professor at Boston University.
Dr. Perrine's education includes a graduate degree from Harvard University and a doctorate from Tufts University.

Susan P. Perrine active positions

Companies	Position	Start
Boston University Boston University Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

All active positions of Susan P. Perrine

Former positions of Susan P. Perrine

Companies	Position	End
Viracta Subsidiary, Inc. Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus	Founder	-
HemaQuest Pharmaceuticals, Inc. HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics	Founder	-

See the detail of Susan P. Perrine's experience

Training of Susan P. Perrine

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Susan P. Perrine's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Boston University Boston University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tufts University Tufts University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
HemaQuest Pharmaceuticals, Inc. HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics	Health Technology
Viracta Subsidiary, Inc. Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus	Health Technology